TFF3 and colorectal cancer: ROC curve analysis showed that serum TFF3 had 76.6% of positive predictive value, 77.3% sensitivity and 72.5% specificity, with an AUC of 0.819 and optimal cut-off (8.83 ng/ml), when colorectal cancer patients were separated from healthy individuals.